Researchers have developed an automatic algorithm that combines tomographic images of an in situ corneal graft into a 3-D model that can reveal an otherwise undetectable signal of graft rejection.
See the impact of this rare autoimmune disease.
Read more about TEPEZZA.
TEPEZZA is a trademark owned by or licensed to Horizon.© 2021 Horizon Therapeutics plc P-TEP-01183 08/21
Public & Patients
Museum of the Eye